Related Experiment Video
Updated: Apr 17, 2026

Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery
Published on: May 24, 2021
More Than Skin Deep: A Case of Stroke Secondary to Hidradenitis Suppurativa
Danielle Lacasse1, Ngun Cer Chin2, Ashley Otto1
1Department of Internal Medicine, Naval Medical Center Portsmouth, Portsmouth, VA 23708, United States.
Insights
Hidradenitis suppurativa (HS), a chronic inflammatory skin condition, may cause cryptogenic ischemic strokes in young adults. Prompt diagnosis and treatment of HS can prevent recurrent neurological events and reduce long-term cardiovascular risks.
Area of Science:
- Rheumatology
- Neurology
- Dermatology
Background:
- Cryptogenic ischemic strokes in young adults lack identified causes.
- Systemic inflammatory diseases like rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are linked to early atherosclerotic cardiovascular disease (ASCVD).
- Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition with shared inflammatory pathways but is underrecognized as a cardiovascular risk factor.
Purpose of the Study:
- To highlight Hidradenitis Suppurativa (HS) as a potential cause of cryptogenic ischemic stroke.
- To emphasize the importance of recognizing HS as a systemic disease with cardiovascular and neurological implications.
- To underscore the need for early diagnosis and treatment of HS to mitigate long-term morbidity.
Main Methods:
- Case report of a 28-year-old active-duty service member with cryptogenic ischemic stroke.
- Initial comprehensive evaluation including vascular imaging, echocardiography, telemetry, autoimmune, and coagulation testing.
- Diagnosis of advanced HS (Hurley stage III) and treatment with adalimumab during follow-up.
Main Results:
- The patient's ischemic stroke was initially classified as cryptogenic.
- Advanced HS was diagnosed post-stroke.
- Treatment with adalimumab resulted in dermatologic improvement and prevented further neurological events.
Conclusions:
- Hidradenitis Suppurativa (HS) should be considered a potential cause of cryptogenic ischemic stroke due to chronic systemic inflammation.
- Recognizing HS as a systemic disease is critical for managing its cardiovascular and neurological effects.
- Early diagnosis and treatment of HS may reduce long-term morbidity, particularly in young military populations.
Abstract:
Ischemic strokes in young adults are often classified as cryptogenic when standard evaluation fails to identify an underlying cause. Growing evidence connects systemic inflammatory diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), to early-onset atherosclerotic cardiovascular disease (ASCVD) that is driven by proinflammatory cytokines and endothelial dysfunction. Hidradenitis suppurativa (HS), a chronic inflammatory skin condition marked by recurrent abscesses and sinus tracts, shares similar inflammatory pathways but remains underrecognized as a cardiovascular risk factor. We report the case of a 28-year-old active-duty service member who presented with acute ischemic stroke after prior transient visual disturbances. Initial evaluation, including vascular imaging, echocardiography, telemetry, autoimmune and coagulation testing, was unrevealing, and the stroke was labeled cryptogenic. At follow-up, advanced HS (Hurley stage III) was diagnosed, and treatment with adalimumab led to both dermatologic improvement and absence of further neurologic events. This case emphasizes HS as a possible cause of cryptogenic ischemic stroke because of chronic systemic inflammation. Recognizing HS as a systemic disease with cardiovascular and neurological effects is critical. Early diagnosis and prompt treatment may lower long-term morbidity, especially in young military populations where early vascular events have major personal and occupational consequences.
Related Concept Videos
Atherosclerosis IV: Nursing Management
Peripheral Artery Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Rheumatic Heart Disease I: Introduction
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Peripheral Artery Disease III: Interprofessional Care